Sabra Healthcare REIT (SBRA) Set to Post Quarterly Earnings on Monday

Sabra Healthcare REIT (NASDAQ:SBRA) is projected to release its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect the company to post earnings of $0.1637 per share and revenue of $236.64 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 1:00 PM ET.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. During the same quarter in the previous year, the firm posted $0.38 earnings per share. The firm’s quarterly revenue was up 24.7% on a year-over-year basis. On average, analysts expect Sabra Healthcare REIT to post $1.52 EPS for the current fiscal year and $1.60 EPS for the next fiscal year.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA opened at $19.56 on Monday. The company’s 50-day moving average price is $19.97 and its two-hundred day moving average price is $20.06. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. Sabra Healthcare REIT has a one year low of $17.17 and a one year high of $22.77. The stock has a market capitalization of $5.00 billion, a PE ratio of 75.23, a price-to-earnings-growth ratio of 1.78 and a beta of 0.63.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 461.54%.

Insider Activity

In related news, CEO Richard Matros sold 200,000 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on SBRA. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Wells Fargo & Company reduced their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating for the company in a research report on Monday, October 19th. Citizens Jmp increased their price target on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 22nd. Robert W. Baird raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. Finally, Mizuho set a $21.00 price target on Sabra Healthcare REIT in a research report on Monday, August 31st. Seven research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $21.50.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.